Logo image of ACR.OL

AXACTOR ASA (ACR.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:ACR - NO0010840515 - Common Stock

7.6 NOK
-0.16 (-2.06%)
Last: 1/7/2026, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACR. ACR was compared to 9 industry peers in the Consumer Finance industry. Both the profitability and financial health of ACR have multiple concerns. ACR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACR had negative earnings in the past year.
In the past year ACR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
In multiple years ACR reported negative operating cash flow during the last 5 years.
ACR.OL Yearly Net Income VS EBIT VS OCF VS FCFACR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACR (-4.57%) is worse than 77.78% of its industry peers.
ACR has a Return On Equity of -16.24%. This is in the lower half of the industry: ACR underperforms 77.78% of its industry peers.
With a Return On Invested Capital value of 1.01%, ACR perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROIC 1.01%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ACR.OL Yearly ROA, ROE, ROICACR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Operating Margin of ACR (9.90%) is comparable to the rest of the industry.
With a decent Gross Margin value of 98.12%, ACR is doing good in the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of ACR has grown nicely.
Industry RankSector Rank
OM 9.9%
PM (TTM) N/A
GM 98.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
ACR.OL Yearly Profit, Operating, Gross MarginsACR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

ACR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACR has about the same amount of shares outstanding.
ACR has more shares outstanding than it did 5 years ago.
ACR has a worse debt/assets ratio than last year.
ACR.OL Yearly Shares OutstandingACR.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACR.OL Yearly Total Debt VS Total AssetsACR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

ACR has an Altman-Z score of 0.24. This is a bad value and indicates that ACR is not financially healthy and even has some risk of bankruptcy.
ACR has a Altman-Z score (0.24) which is comparable to the rest of the industry.
The Debt to FCF ratio of ACR is 4.17, which is a neutral value as it means it would take ACR, 4.17 years of fcf income to pay off all of its debts.
ACR has a Debt to FCF ratio of 4.17. This is in the better half of the industry: ACR outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 2.25 is on the high side and indicates that ACR has dependencies on debt financing.
The Debt to Equity ratio of ACR (2.25) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Altman-Z 0.24
ROIC/WACC0.12
WACC8.31%
ACR.OL Yearly LT Debt VS Equity VS FCFACR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.99 indicates that ACR may have some problems paying its short term obligations.
ACR has a better Current ratio (0.99) than 66.67% of its industry peers.
ACR has a Quick Ratio of 0.99. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
ACR has a Quick ratio of 0.99. This is in the better half of the industry: ACR outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
ACR.OL Yearly Current Assets VS Current LiabilitesACR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

ACR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -379.79%.
The Revenue for ACR has decreased by -37.28% in the past year. This is quite bad
ACR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.81% yearly.
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3100%
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%12.26%

3.2 Future

The Earnings Per Share is expected to grow by 36.40% on average over the next years. This is a very strong growth
ACR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.14% yearly.
EPS Next Y144.8%
EPS Next 2Y60.9%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue Next Year45.87%
Revenue Next 2Y23.74%
Revenue Next 3Y16.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACR.OL Yearly Revenue VS EstimatesACR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ACR.OL Yearly EPS VS EstimatesACR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.14, which indicates a rather cheap valuation of ACR.
100.00% of the companies in the same industry are more expensive than ACR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.57. ACR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.14
ACR.OL Price Earnings VS Forward Price EarningsACR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

ACR's Enterprise Value to EBITDA is on the same level as the industry average.
ACR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACR is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1
EV/EBITDA 38.38
ACR.OL Per share dataACR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACR's earnings are expected to grow with 36.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.9%
EPS Next 3Y36.4%

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AXACTOR ASA

OSL:ACR (1/7/2026, 7:00:00 PM)

7.6

-0.16 (-2.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-12 2026-02-12/amc
Inst Owners8.78%
Inst Owner ChangeN/A
Ins Owners3.29%
Ins Owner ChangeN/A
Market Cap2.30B
Revenue(TTM)147.84M
Net Income(TTM)-58.22M
Analysts75
Price Target9.59 (26.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.44%
Min EPS beat(2)-24.09%
Max EPS beat(2)15.21%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.81%
Min Revenue beat(2)-13.86%
Max Revenue beat(2)0.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.08%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)-0.49%
EPS NY rev (3m)-4.56%
Revenue NQ rev (1m)1.56%
Revenue NQ rev (3m)-0.76%
Revenue NY rev (1m)-3.73%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.14
P/S 1.31
P/FCF 1
P/OCF 0.98
P/B 0.54
P/tB 0.67
EV/EBITDA 38.38
EPS(TTM)-3.11
EYN/A
EPS(NY)1.83
Fwd EY24.13%
FCF(TTM)7.63
FCFY100.33%
OCF(TTM)7.75
OCFY102.03%
SpS5.79
BVpS14.05
TBVpS11.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROCE 1.25%
ROIC 1.01%
ROICexc 1.05%
ROICexgc 1.12%
OM 9.9%
PM (TTM) N/A
GM 98.12%
FCFM 131.59%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Debt/EBITDA 32.14
Cap/Depr 31.37%
Cap/Sales 2.23%
Interest Coverage 0.2
Cash Conversion 787.27%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.24
F-Score3
WACC8.31%
ROIC/WACC0.12
Cap/Depr(3y)41.35%
Cap/Depr(5y)45.86%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3100%
EPS Next Y144.8%
EPS Next 2Y60.9%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%12.26%
Revenue Next Year45.87%
Revenue Next 2Y23.74%
Revenue Next 3Y16.14%
Revenue Next 5YN/A
EBIT growth 1Y-86.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year126.34%
EBIT Next 3Y33.79%
EBIT Next 5YN/A
FCF growth 1Y1123.46%
FCF growth 3Y9.09%
FCF growth 5YN/A
OCF growth 1Y901.89%
OCF growth 3Y8.3%
OCF growth 5YN/A

AXACTOR ASA / ACR.OL FAQ

What is the ChartMill fundamental rating of AXACTOR ASA (ACR.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACR.OL.


Can you provide the valuation status for AXACTOR ASA?

ChartMill assigns a valuation rating of 6 / 10 to AXACTOR ASA (ACR.OL). This can be considered as Fairly Valued.


What is the profitability of ACR stock?

AXACTOR ASA (ACR.OL) has a profitability rating of 2 / 10.


Is the dividend of AXACTOR ASA sustainable?

The dividend rating of AXACTOR ASA (ACR.OL) is 0 / 10 and the dividend payout ratio is 0%.